Hexavest Has Trimmed Valeant Pharmaceuticco L (VRX) Position; Blonder Tongue Labs (NYSEMKT:BDR) Sellers Decreased By 22.22% Their Shorts

August 8, 2017 - By Dolores Ford

Blonder Tongue Labs Incorporated (NYSEMKT:BDR) had a decrease of 22.22% in short interest. BDR’s SI was 1,400 shares in August as released by FINRA. Its down 22.22% from 1,800 shares previously. With 3,100 avg volume, 1 days are for Blonder Tongue Labs Incorporated (NYSEMKT:BDR)’s short sellers to cover BDR’s short positions. The SI to Blonder Tongue Labs Incorporated’s float is 0.03%. The stock decreased 1.77% or $0.01 on August 7, reaching $0.56. About shares traded. Blonder Tongue Labs, Inc. (NYSEMKT:BDR) has risen 27.91% since August 8, 2016 and is uptrending. It has outperformed by 11.21% the S&P500.

Hexavest Inc decreased Valeant Pharmaceuticco L (VRX) stake by 88.55% reported in 2016Q4 SEC filing. Hexavest Inc sold 3.33 million shares as Valeant Pharmaceuticco L (VRX)’s stock declined 15.71%. The Hexavest Inc holds 431,343 shares with $6.26 million value, down from 3.77 million last quarter. Valeant Pharmaceuticco L now has $5.26B valuation. The stock rose 8.98% or $1.38 reaching $16.75. About 2.13M shares traded. Valeant Pharmaceuticals Intl Inc (NYSE:VRX) has declined 48.51% since August 8, 2016 and is downtrending. It has underperformed by 65.21% the S&P500.

Blonder Tongue Laboratories, Inc. , along with its subsidiary, R. The company has market cap of $4.55 million. L. It currently has negative earnings. Drake Holdings, LLC (RLD), is a technology-development and manufacturing company.

Hexavest Inc increased Magna Intl Inc (NYSE:MGA) stake by 208,476 shares to 350,174 valued at $15.22 million in 2016Q4. It also upped Alibaba Group Hldg Util (NYSE:BABA) stake by 12,937 shares and now owns 211,825 shares. Parkland Fuel Corp (PKIUF) was raised too.

Among 26 analysts covering Valeant Pharmaceuticals Intl (NYSE:VRX), 6 have Buy rating, 3 Sell and 17 Hold. Therefore 23% are positive. Valeant Pharmaceuticals Intl had 115 analyst reports since July 21, 2015 according to SRatingsIntel. The firm earned “Buy” rating on Tuesday, August 9 by Rodman & Renshaw. As per Friday, October 14, the company rating was maintained by Deutsche Bank. Piper Jaffray maintained it with “Underweight” rating and $11 target in Wednesday, January 4 report. The rating was maintained by Stifel Nicolaus on Thursday, June 29 with “Buy”. RBC Capital Markets maintained Valeant Pharmaceuticals Intl Inc (NYSE:VRX) rating on Wednesday, November 11. RBC Capital Markets has “Outperform” rating and $206 target. Barclays Capital downgraded Valeant Pharmaceuticals Intl Inc (NYSE:VRX) rating on Monday, March 21. Barclays Capital has “Equal-Weight” rating and $34 target. BMO Capital Markets maintained the stock with “Hold” rating in Tuesday, July 25 report. Jefferies maintained it with “Buy” rating and $172 target in Monday, November 2 report. As per Thursday, June 23, the company rating was downgraded by JP Morgan. The stock of Valeant Pharmaceuticals Intl Inc (NYSE:VRX) earned “Buy” rating by Stifel Nicolaus on Wednesday, June 8.

Investors sentiment decreased to 0.78 in 2016 Q4. Its down 0.10, from 0.88 in 2016Q3. It turned negative, as 82 investors sold VRX shares while 87 reduced holdings. 49 funds opened positions while 82 raised stakes. 193.03 million shares or 13.22% less from 222.43 million shares in 2016Q3 were reported. Stifel Fin Corporation has invested 0.01% of its portfolio in Valeant Pharmaceuticals Intl Inc (NYSE:VRX). 82,400 are held by Art Ltd Liability. Oxford Asset Management holds 165,521 shares or 0.12% of its portfolio. One Trading LP holds 0.16% in Valeant Pharmaceuticals Intl Inc (NYSE:VRX) or 1.16M shares. The Denmark-based Cam Grp Inc Holding A S has invested 0.06% in Valeant Pharmaceuticals Intl Inc (NYSE:VRX). Fifth Third State Bank owns 181 shares. Pershing Square Capital LP holds 18.11 million shares or 4.45% of its portfolio. First Eagle Investment Ltd Liability Company stated it has 613,800 shares. Laurion Mngmt Limited Partnership accumulated 1.02M shares. Apg Asset Mgmt Nv owns 372,260 shares. Highbridge Ltd has invested 0% in Valeant Pharmaceuticals Intl Inc (NYSE:VRX). Cibc Ww Mkts owns 3.59M shares for 0.21% of their portfolio. Alexandria Lc reported 32 shares. Rock Springs Capital Management LP has invested 0.07% of its portfolio in Valeant Pharmaceuticals Intl Inc (NYSE:VRX). 4,064 are owned by Envestnet Asset Management.